Gustavo M. Petracca
Gustavo M. Petracca publishes mostly in Psychiatry and Mental health, Neurology and Cognitive Neuroscience, on topics such as Dementia and Cognitive Impairment Research, Parkinson's Disease Mechanisms and Treatments and Alzheimer's disease research and treatments.
- World rank
- #780,103 of 7,710,434 ranked researchers
- Rank in United States
- #260,965 of 1,627,098
- Works
- 47
- Citations
- 3.2k
- Citations per work
- 67.5
What does Gustavo M. Petracca research?
Gustavo M. Petracca's work is mostly in Medicine (48%), Neuroscience (15%), Psychology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2348.0%
- Medicine2348.0%
- Everything else1532.5%
- Life Sciences714.6%
- Neuroscience714.6%
- Social Sciences24.9%
- Psychology24.9%
- 1Psychiatry and Mental health29% of their works
- 2Neurology13% of their works
- 3Cognitive Neuroscience9% of their works
- 4Neurology6% of their works
- 5Physiology6% of their works
- 6Clinical Psychology5% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Parkinson's Disease Mechanisms and Treatments
- Alzheimer's disease research and treatments
- Neurological disorders and treatments
- Treatment of Major Depression
- Spatial Neglect and Hemispheric Dysfunction
- Neurological Disorders and Treatments
- Schizophrenia research and treatment
Which keywords describe Gustavo M. Petracca's research?
The keywords of their largest research topics: Alzheimer's Disease, Dementia, Mild Cognitive Impairment, Oxidative Stress, Neurodegeneration, Parkinson's Disease, Mitochondrial Dysfunction and Treatment-Resistant Depression.
- Spatial Neglect
- Citicoline
- Attention Networks
- Depression
- Subthalamic Nucleus
- Tau Pathology
- a-Synuclein
- Treatment-Resistant Depression
- Parkinson's Disease
- Oxidative Stress
- Dementia
- Alzheimer's Disease
- Mild Cognitive Impairment
- Neurodegeneration
- Mitochondrial Dysfunction
- Dopaminergic Neurons
- Amyloid Hypothesis
- Deep Brain Stimulation
- Antidepressant
- Antipsychotic Drugs
- Cerebrolysin
- Neurocognitive Deficits
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Alzheimer's Disease262 topics
- Dementia221 topic
- Mild Cognitive Impairment221 topic
- Oxidative Stress213 topics
- Neurodegeneration172 topics
- Parkinson's Disease162 topics
- Mitochondrial Dysfunction142 topics
- Treatment-Resistant Depression112 topics
- Dopaminergic Neurons101 topic
- a-Synuclein101 topic
- Amyloid Hypothesis71 topic
- Tau Pathology71 topic
- Deep Brain Stimulation61 topic
- Subthalamic Nucleus61 topic
- Antidepressant51 topic
- Depression51 topic
- Antipsychotic Drugs41 topic
- Attention Networks41 topic
- Cerebrolysin41 topic
- Citicoline41 topic
- Neurocognitive Deficits41 topic
- Spatial Neglect41 topic
Where does Gustavo M. Petracca work?
Gustavo M. Petracca's main affiliation in the publication record is Neurological Research Institute, United States.
How many publications and citations does Gustavo M. Petracca have?
OpenAlex counts 47 works and 3,174 citations for Gustavo M. Petracca, an h-index of 23, ranking #780,103 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Gustavo M. Petracca. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.